ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity.
about
Twenty years of anti-HER2 therapy-associated cardiotoxicityAn Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice.Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older PatientsVEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.Divergent Effects of miR-181 Family Members on Myocardial Function Through Protective Cytosolic and Detrimental Mitochondrial microRNA Targets.Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs.Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration.Breast cancer treatment-induced cardiotoxicity.Letter to the editor: "Doxorubicin and ErbB2 overexpression: another piece in the mitochondrial jigsaw".Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.Synergistic effects of polydatin and vitamin C in inhibiting cardiotoxicity induced by doxorubicin in rats.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.3,3'-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen speciesElectrochemically Reduced Water Delays Mammary Tumors Growth in Mice and Inhibits Breast Cancer Cells Survival
P2860
Q28079391-BD27E335-9614-44FD-8942-F7601332AA73Q36247553-1E46A00E-31ED-4F3D-9491-16E243DD1148Q36339397-A0A9ACBF-6678-4F16-855A-11C1FAE148F6Q37191051-A9E712C7-0296-4ED1-B23E-BB0158CADF5BQ37469455-DF0EC823-F005-47ED-9429-09F968440ADCQ38714584-BB96F4E7-FCCB-4FC4-B503-286827143752Q39102231-17ABDAFF-AC36-43DF-88F9-6FDD78E61973Q39129349-B2066576-75C4-4309-92B9-ACC3B3BA3D18Q39428826-1724587E-025E-461F-A612-1A0FEEAA3108Q48228423-22B90EB9-0868-49EF-AF03-3B5F43004A7BQ50146298-64061701-EDCC-4208-972C-CEC003EE5805Q51092286-EA54A54E-91A2-4C79-939E-408C9DD6EC5BQ51760757-2001931A-C546-4FA6-BC6A-486ABC9AA4B8Q54976923-A955E527-F8DD-4E6C-BA42-6E7A9A322E37Q57279728-0AA326E6-103A-4CB7-B003-A4DEBC2406C5Q58550380-DEDBCDDA-5208-4664-9DA1-25DF09999060
P2860
ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
ErbB2 overexpression upregulat ...... st doxorubicin cardiotoxicity.
@ast
ErbB2 overexpression upregulat ...... st doxorubicin cardiotoxicity.
@en
type
label
ErbB2 overexpression upregulat ...... st doxorubicin cardiotoxicity.
@ast
ErbB2 overexpression upregulat ...... st doxorubicin cardiotoxicity.
@en
prefLabel
ErbB2 overexpression upregulat ...... st doxorubicin cardiotoxicity.
@ast
ErbB2 overexpression upregulat ...... st doxorubicin cardiotoxicity.
@en
P2093
P2860
P1476
ErbB2 overexpression upregulat ...... nst doxorubicin cardiotoxicity
@en
P2093
Brian Stanley
Charles Steenbergen
Frances Belmonte
Kathleen Gabrielson
Masaki Nagane
Miguel A Aon
Periannan Kuppusamy
Polina Sysa-Shah
Samarjit Das
Vidhya Sivakumaran
P2860
P304
P356
10.1152/AJPHEART.00517.2014
P577
2015-08-07T00:00:00Z